The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.00
Bid: 29.10
Ask: 29.70
Change: -0.90 (-3.01%)
Spread: 0.60 (2.062%)
Open: 29.00
High: 29.10
Low: 29.00
Prev. Close: 29.90
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cancellation of share options

26 Jun 2017 07:00

RNS Number : 0676J
EKF Diagnostics Holdings PLC
26 June 2017
 

EKF Diagnostics Holdings plc

("EKF", the "Company")

 

Cancellation of share options

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that 21,614,766 share options over ordinary shares of 1 penny each (the "Ordinary Shares") granted to certain directors, PDMRs, employees and the former Chairman of the Company (the "Options") have been cancelled at the election of those holding the options (the "Optionholders") in return for the payment of a one-off cash sum.

 

Details of the cancellation of the Options are set out below:

 

PDMR

Role

Number of Options being surrendered

Cash payment (£)

Julian Baines

CEO

5,127,383

354,348

Richard Evans

COO and CFO

4,260,000

294,826

Steven Wray

Head of Sales EMEA

825,000

61,801

Gilbert Mejia

Head of Sales Americas

800,000

60,522

Martyn Lewis

Head of Marketing

800,000

61,551

Peter Coyne

Head of Operations

800,000

61,551

Ed Hitchler

General Manager, EKF USA

800,000

59,914

Steffen Borlich

General Manager, EKF Germany

800,000

61,893

Salim Hamir

Company Secretary and Head of Corporate Affairs

600,000

46,802

Colin Anderson

Deputy Finance Director

700,000

46,802

Other employees and the former Chairman

Various

6,102,383

395,331

Total

21,614,766

1,505,341

 

The cash sum to be paid to each relevant Optionholder has been calculated by reference to the mid-market share price of 21.5p, being the price at the time the offer was made to the Optionholders, with certain tax and other adjustments being applied.

 

The purpose of this cancellation is to try and simplify the Company's capital structure ahead of the previously announced intended proposed share buyback and to reduce future dilution to shareholders.

 

Following the cancellation, share options remain over a total of 1,950,000 Ordinary Shares and these are exercisable at various prices of between 20p and 37.625p and expire between 7 July 2023 and 6 April 2025.

 

As at 23 June 2017 the Company had net cash balances of approximately £3.9m after deduction of the £1.5m to be paid to the various Optionholders as set out above.

 

EKF Diagnostics Holdings plc 

www.ekfdiagnostics.com

Christopher Mills, Non-Executive Chairman

Tel: 029 2071 0570

Julian Baines, CEO 

Richard Evans, FD & COO

N+1 Singer (Nomad & Broker)

Tel: 020 7496 3000

Alex Price / Shaun Dobson / Ali Laughton-Scott

Walbrook PR Limited

Tel: 020 7933 8780 or ekf@walbrookpr.com

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

 

 

a)

 

Names 

Julian Baines - Chief Executive Officer

Richard Evans - Chief Operating Officer and Finance Director

Steven Wray - Head of Sales EMEA

Gilbert Mejia - Head of Sales Americas

Martyn Lewis - Head of Marketing

Peter Coyne - Head of Operations

Ed Hitchler - General Manager, EKF USA

Steffen Borlich - General Manager, EKF Germany

Salim Hamir - Company Secretary and Head of Corporate Affairs

Colin Anderson - Deputy Finance Director

2

 

Reason for the notification

a)

 

Position/status

 

See 1(a) above for positions - all classified as PDMRs of EKF

b)

 

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

EKF Diagnostics Holdings plc

b)

 

LEI

213800DXTF3EAUK1AR05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument 

In each case, the grant of Options over Ordinary Shares

b)

Identification code 

GB0031509804

c)

 

Nature of the transaction 

Cancellation of Options over Ordinary Shares 

d)

 

Price(s) and volume(s)

Price - n/a

Volume(s)

Julian Baines - 5,127,383 Options

Richard Evans - 4,260,000 Options

Steven Wray - 825,000 Options

Gilbert Mejia - 800,000 Options

Martyn Lewis - 800,000 Options

Peter Coyne - 800,000 Options

Ed Hitchler - 800,000 Options

Steffen Borlich - 800,000 Options

Salim Hamir -600,000 Options

Colin Anderson - 700,000 Options

 

d)

 

Aggregated information 

- Aggregated volume

- Price

 

15,512,383

N/A

e)

 

Date of the transaction 

26 June 2017

f)

 

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEASKDALFXEFF
Date   Source Headline
25th Aug 20151:10 pmRNSHolding(s) in Company
25th Aug 201511:54 amPRNForm 8.3 - EKF Diagnostics Holdings Plc
25th Aug 201511:30 amBUSForm 8.3 - EKF Diagnostics Holdings Plc
25th Aug 201510:52 amRNSHolding(s) in Company
24th Aug 201511:19 amRNSForm 8.3 - EKF Diagnostics Holdings Plc
24th Aug 20157:01 amRNSAnnouncement under rule 2.4 of the Takeover Code
24th Aug 20157:00 amRNSFurther non-binding proposal
18th Aug 201512:00 pmRNSConclusion of Strategic Review
18th Aug 201511:55 amRNSTrading update
10th Aug 20159:25 amRNSHolding(s) in Company
19th May 20152:26 pmRNSResult of AGM
13th May 20157:00 amRNSLaunch of PrecisionPath Colon
1st May 20153:15 pmRNSPosting of Annual Report & Notice of AGM
24th Apr 20154:44 pmRNSHolding(s) in Company
21st Apr 20151:17 pmRNSData for PointMan Technology presented at AACR
8th Apr 201511:41 amRNSHolding(s) in Company
8th Apr 201511:36 amRNSHolding(s) in Company
2nd Apr 20157:00 amRNSShareholder update
26th Mar 20153:47 pmRNSHolding(s) in Company
25th Mar 20153:05 pmRNSHolding(s) in Company
19th Mar 20159:40 amRNSHolding(s) in Company
18th Mar 20153:41 pmRNSHolding(s) in Company
16th Mar 20157:00 amRNSFinal Results
2nd Mar 20157:00 amRNSCollaboration to improve colon cancer treatment
23rd Feb 20157:00 amRNSNotice of results & investor results presentation
2nd Feb 20157:00 amRNSChange of Adviser
28th Jan 20157:00 amRNSTrading update
23rd Jan 20157:00 amRNSCorporate Collaboration
23rd Jan 20157:00 amRNSPointMan collaboration with ANGLE plc
5th Jan 20157:00 amRNSPayment of DiaSpect's deferred consideration
17th Dec 20147:00 amRNSTrading update & potential Board appointment
11th Nov 20144:46 pmRNSHolding(s) in Company
1st Oct 201411:36 amRNSDirector/PDMR Shareholding
23rd Sep 20147:00 amRNSUS collaboration to develop blood tests for cancer
15th Sep 20147:00 amRNSHalf Yearly Report
15th Aug 20147:00 amRNSDirectorate Change
13th Aug 20147:00 amRNSNotice of results and investor briefing
23rd Jul 20147:00 amRNSTrading update
8th Jul 20147:00 amRNSContract Win and Regulatory Approval
13th Jun 201412:53 pmRNSHolding(s) in Company
9th Jun 20145:59 pmRNSGrant of Share Options
6th Jun 20142:46 pmRNSHolding(s) in Company
2nd Jun 20144:15 pmRNSHolding(s) in Company
2nd Jun 20147:00 amRNSMajor step towards detecting cancer in blood
2nd Jun 20147:00 amRNSDirectorate Change
27th May 20143:59 pmRNSHolding(s) in Company
23rd May 201411:30 amRNSHolding(s) in Company
21st May 20144:40 pmRNSSecond Price Monitoring Extn
21st May 20144:35 pmRNSPrice Monitoring Extension
20th May 20144:36 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.